@misc{indiciaeee650724e00c,
  title = {Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML},
  author = {Pianigiani, G. and Gagliardi, A. and Mezzasoma, F. and Rocchio, F. and Tini, V. and Bigerna, B. and Sportoletti, P. and Caruso, S. and Marra, A. and Spinozzi, G. and Shacham, S. and Landesman, Y. and Quintarelli, C. and Locatelli, F. and Martelli, M. P. and Falini, B. and Brunetti, L.},
  year = {2021},
  doi = {10.1101/2021.12.11.472216},
  url = {https://www.biorxiv.org/content/10.1101/2021.12.11.472216v1},
  note = {Source identifier: 10.1101/2021.12.11.472216}
}